PYXS
Pyxis Oncology Inc
2.00$
-0.5%
vs. previous close
Closing price · As of: Oct 7, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +31.9% | +61.7% | -47.6% | +25.0% | -24.8% | +0.4% | -3.1% | -1.5% | +449.7% | -84.2% | -34.4% | – | |
| – | -37.9% | +34.4% | -33.5% | +3.8% | -7.0% | +30.9% | -17.0% | +1.9% | -32.2% | -41.9% | +356.9% | – | |
| – | -311.7% | – | – | -65.1% | -254.9% | – | – | – | -47.6% | -253.6% | – | – | |
| – | -100.0% | – | -100.0% | – | – | – | – | – | -100.0% | – | – | – | |
| – | +55.7% | -280.9% | – | -300.0% | – | -40.6% | -3.3% | -25.0% | +41.8% | +0.7% | +30.1% | – | |
| – | -86.8% | +376,823.1% | -78.1% | -97.7% | +764,900.0% | – | – | – | – | – | – | – | |
| – | -85.4% | – | -99.8% | +1,404.5% | -97.0% | -100.0% | – | -88.1% | – | -103.7% | – | – | |
| – | – | – | -115.8% | – | – | -190.5% | – | – | – | -248.5% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.